Analyst
RBC
Equibles does not estimate personal net worth.
Leona Temeshev is recorded as Analyst at RBC. Leona Temeshev has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Exelixis, Inc. on October 29, 2026. Those appearances were for Exelixis, Inc. (EXEL), Design Therapeutics, Inc. (DSGN) and Jazz Pharmaceuticals plc (JAZZ). The companies whose calls Leona Temeshev spoke on are classified in the Healthcare sector.
“I wanted to ask on Stellar 316 and maybe how you're thinking about expectations there.”
“On the biomarker slide, it says that the statistical significance was against untreated individuals. Does that mean that this was the patient's baseline, or was there another cohort being compared to?”
“I wanted to stay with, you mentioned epilepsy. I just wanted to touch on that. You've been making a lot of investments in that area, both with Epidiolex, the Sinoni asset.”
RBC
Analyst
Transcript header (unverified)
EXEL
Biotechnology · Healthcare
